Showing 1 - 20 results of 45 for search 'Tadaaki Yamada', query time: 0.08s
Refine Results
-
1
-
2
Tumor Neovascularization and Developments in Therapeutics by Yuki Katayama, Junji Uchino, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama
Published 2019-03-01
Article -
3
-
4
Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives by Martin E. Hale, James E. Wild, Tadaaki Yamada, Takaaki Yokota, Jan Tack, Viola Andresen, Asbjørn Mohr Drewes
Published 2021-07-01
Article -
5
-
6
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients by Tatsuya Imabayashi, Junji Uchino, Hisayuki Osoreda, Keiko Tanimura, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Koichi Takayama
Published 2019-02-01
Article -
7
Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study) by Tadaaki Yamada, Junji Uchino, Yusuke Chihara, Takayuki Shimamoto, Masahiro Iwasaku, Nobuyo Tamiya, Yoshiko Kaneko, Fumiaki Kiyomi, Koichi Takayama
Published 2020-05-01
Article -
8
-
9
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high... by Hayato Kawachi, Tadaaki Yamada, Akihiro Yoshimura, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Young Hak Kim, Takayuki Shimose, Koichi Takayama
Published 2023-06-01
Article -
10
Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis by Akihiro Yoshimura, Tadaaki Yamada, Taisuke Tsuji, Ryosuke Hamashima, Shinsuke Shiotsu, Tatsuya Yuba, Chieko Takumi, Junji Uchino, Noriya Hiraoka, Koichi Takayama
Published 2019-03-01
Article -
11
Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study) by Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Shigeki Nanjo, Tadaaki Yamada, Koshiro Ohtsubo, Seiji Yano, Atsushi Mizokami
Published 2021-08-01
Article -
12
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case report by Shota Takei, Akihiro Yoshimura, Chie Yamamoto, Seita Kataoka, Nobutaka Kataoka, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Tadaaki Yamada, Takayuki Takeda, Koichi Takayama
Published 2023-09-01
Article -
13
Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib by Takayuki Takeda, Tadaaki Yamada, Keiko Tanimura, Takayuki Nakano, Masaki Ishida, Yusuke Tachibana, Shinsuke Shiotsu, Shigeto Horiuchi, Makoto Hibino, Asuka Okada, Yusuke Chihara, Koichi Takayama
Published 2021-11-01
Article -
14
Recurrence of Large-Vessel Vasculitis Induced by Multiple Types of Granulocyte Colony-Stimulating Factor Preparation in Patient with Large-Cell Neuroendocrine Lung Carcinoma: A Cas... by Yurie Seto, Tadaaki Yamada, Masashi Egami, Takumi Sugimoto, Izumi Sato, Satomi Tanaka, Yusuke Chihara, Kenji Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Yoshiko Kaneko, Koichi Takayama
Published 2023-09-01
Article -
15
Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study by Masaki Ishida, Kenji Morimoto, Tadaaki Yamada, Shinsuke Shiotsu, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Takayuki Takeda, Koichi Takayama
Published 2022-01-01
Article -
16
Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitors. by Shigeki Nanjo, Tadaaki Yamada, Hiroshi Nishihara, Shinji Takeuchi, Takako Sano, Takayuki Nakagawa, Daisuke Ishikawa, Lu Zhao, Hiromichi Ebi, Kazuo Yasumoto, Kunio Matsumoto, Seiji Yano
Published 2013-01-01
Article -
17
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation by Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, Takayuki Takeda, Kazuki Hirose, Yutaka Kubota, Shinsuke Shiotsu, Osamu Hiranuma, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Published 2019-03-01
Article -
18
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations by Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, Takayuki Takeda, Wataru Furutani, Yutaka Kubota, Shinsuke Shiotsu, Osamu Hiranuma, Naoya Nishioka, Yusuke Chihara, Nobuyo Tamiya, Yoshiko Kaneko, Junji Uchino, Koichi Takayama
Published 2018-12-01
Article -
19
Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR‐TKI in non–small cell lung cancer patients with EGFR mutation: A multicenter retrospective study by Tae Hata, Chikara Sakaguchi, Keita Hirano, Hiroshi Kobe, Masaki Ishida, Takayuki Nakano, Yusuke Tachibana, Nobuyo Tamiya, Shinsuke Shiotsu, Takayuki Takeda, Tadaaki Yamada, Toshihide Yokoyama, Michiko Tsuchiya, Yukio Nagasaka
Published 2023-04-01
Article -
20
Pembrolizumab monotherapy for untreated PD-L1-Positive non-small cell lung cancer in the elderly or those with poor performance status: A prospective observational study by Shinsuke Shiotsu, Akihiro Yoshimura, Tadaaki Yamada, Kenji Morimoto, Michiko Tsuchiya, Hiroshige Yoshioka, Osamu Hiranuma, Yusuke Chihara, Takahiro Yamada, Isao Hasegawa, Takahiro Ohta, Takayuki Takeda, Noriya Hiraoka, Koichi Takayama
Published 2022-09-01
Article